Pharmabiz2h
Alnylam reports interim phase 1 data of nucresiran showing rapid knockdown of TTR that is sustained at six months following a single dose
Cambridge, Massachusetts Tuesday, November 19, 2024, 18:00 Hrs [IST] ...
Pharmabiz1h
Lupin introduces bumetanide injection, USP in United States
Global pharma major Lupin Limited (Lupin) announced the launch of United Food and Drug Administration (FDA) approved bumetanide injection USP, 1 mg/4 mL (0.25 mg/mL) single-dose vials and 2.5 mg/10 mL ...
Pharmabiz4h
BioCryst launches Orladeyo in Ireland for routine prevention of recurrent attacks of HAE in patients 12 years and older
Research Triangle Park, North Carolina Tuesday, November 19, 2024, 16:00 Hrs [IST] ...
Pharmabiz3h
Boston Scientific WATCHMAN FLX LAAC device demonstrates superior bleeding risk reduction to OAC following a cardiac ablation in OPTION clinical trial
Marlborough, Massachusetts Tuesday, November 19, 2024, 17:00 Hrs [IST] ...
Pharmabiz4h
Emcure Pharma’s SAKHI - Diabetes Awareness Programme makes it to Asia Book of Records
Emcure Pharma’s SAKHI - Diabetes Awareness Programme makes it to Asia Book of Records: Our Bureau, Mumbai Tuesday, November 19, 2024, 15:30 Hrs [IST] Emcure Pharmaceuticals, a l ...
Pharmabiz4h
LIfT BioSciences expands manufacturing &clinical operations with the opening of new subsidiary in Galway, Ireland
LIfT BioSciences, a rapidly emerging biotech company preparing to start clinical trials for its first-in-class allogeneic innate cell therapy, announces the expansion of its manufacturing and clinical ...
Pharmabiz5h
EnteroBiotix completes patient recruitment in phase 2 TrIuMPH study of EBX-102-02 in irritable bowel syndrome
Glasgow, Scotland Tuesday, November 19, 2024, 15:00 Hrs [IST] ...
Pharmabiz7h
China NMPA accepts & recommends priority review status to Ascentage Pharma’s NDA for novel Bcl-2 inhibitor, Lisaftoclax to treat r/r CLL/SLL
Rockville, Maryland Tuesday, November 19, 2024, 13:00 Hrs [IST] ...
Pharmabiz6h
Only 4 out of 46 companies inspected showed 100% compliance with Revised Schedule M in Tamil Nadu
In the first phase of the regulatory inspections conducted in 46 pharmaceutical manufacturing companies in Tamil Nadu by the state drug inspectors, it was found that only four companies are 100 ...
Pharmabiz33m
Abbott opens state-of-the-art global manufacturing facility in Kilkenny, Ireland
Abbott, a global healthcare leader, marked the official opening of its state-of-the-art manufacturing facility in Kilkenny, Ireland with a ceremony attended by An Taoiseach, Simon Harris, TD, and ...
Pharmabiz6h
SEC recommends approval of additional indication for BMS' anti-cancer drug nivolumab
The Subject Expert Committee (SEC), under the Central Drugs Standard Control Organisation (CDSCO), has recommended approval of additional indication of US-based Bristol-Myers Squibb's anti-cancer drug ...
Pharmabiz5h
European Union recommends approval of AstraZeneca’s Tagrisso for patients with unresectable EGFR-mutated lung cancer
AstraZeneca’s Tagrisso (osimertinib) has been recommended for approval in the European Union (EU) for the treatment of adult patients with locally advanced, unresectable non-small cell lung cancer ...